SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2184219

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2184219

Generative AI Medical Device Validation Market, By Device Type, By Validation Type, By Deployment Mode, By Application, By End User, By Geography

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Generative AI Medical Device Validation Market is estimated to be valued at USD 186.4 Mn in 2026 and is expected to reach USD 612.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 18.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 186.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 18.50% 2033 Value Projection: USD 612.7 Mn

The global generative AI medical device validation market is the confluence between generative artificial intelligence and regulatory requirements in the medical device development process. Generative artificial intelligence can also help with validation, including automated test-case generation, synthetic patient data, and risk assessment and documentation, allowing manufacturers to increase test efficiency while also maintaining safety and performance standards. These activities shall be performed in accordance with the requirements and standards applicable, including the FDA regulations, ISO 13485, and IEC 62304 as applicable to the device and its intended use.

The increasing use of AI-enabled medical technologies creates the need for strong validation throughout the device lifecycle. Medical device manufacturers, healthcare technology companies and regulatory service providers can use generative AI to accelerate testing, improve documentation and support premarket evaluation and post-market monitoring. But these applications require appropriate supervision by humans, data quality controls and evidence that the output generated is reliable and fit for purpose.

Market Dynamics

The global generative AI medical device validation market is driven by the increasing complexity of software-based and AI-enabled medical devices, growing demand for faster product development and the need to simplify validation workflows. It can help with regulatory documentation, automatically generate test cases, create synthetic datasets for edge case testing. This may help manufacturers to be more efficient and to overcome shortages of specialized validation professionals. Evolving regulatory frameworks for AI-enabled medical devices are also increasing the focus on structured performance evaluation, safety assessment, and lifecycle monitoring.

However, a number of constraints are present in the market, such as regulatory uncertainty, concerns over data privacy and algorithmic bias, lack of standardization of AI-based validation methods, and high implementation and training costs, especially for small and mid-sized manufacturers. Nevertheless, significant opportunities exist within the digital twin-based testing, cloud-based validation platforms and collaborations between AI developers, medical device manufacturers and regulatory stakeholders. Rapid modernization of medical device industries across Asia-Pacific, particularly China, India, and South Korea, may further support regional adoption.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global generative AI medical device validation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include UL Solutions Inc., SGS SA, Intertek Group plc, TUV SUD AG, TUV Rheinland AG, BSI Group The Netherlands B.V., DEKRA SE, Medtronic plc, Siemens Healthineers AG, and Philips N.V.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global generative AI medical device validation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global generative AI medical device validation market

Market Segmentation

  • Device Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Generative AI-Enabled Software as a Medical Device (SaMD)
  • AI-Enabled Medical Devices with Embedded Software
  • Generative AI-Enabled Clinical Decision Support Devices
  • Generative AI-Enabled Diagnostic Devices
  • Validation Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Model Performance Validation
  • Clinical Validation
  • Safety and Risk Validation
  • Usability and Human Factors Validation
  • Post-Market Performance Validation
  • Deployment Mode Phase Insights (Revenue, USD Mn, 2021 - 2033)
  • Cloud-Based
  • On-Premises
  • Hybrid
  • Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Medical Imaging and Diagnostics
  • Clinical Decision Support
  • Patient Monitoring and Predictive Analytics
  • Clinical Documentation and Reporting
  • Treatment Planning and Personalized Medicine
  • Others
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Medical Device Manufacturers
  • Hospitals and Healthcare Systems
  • Contract Research Organizations (CROs)
  • Academic and Research Institutions
  • Regulatory Testing and Validation Laboratories
  • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • UL Solutions Inc.
  • SGS SA
  • Intertek Group plc
  • TUV SUD AG
  • TUV Rheinland AG
  • BSI Group The Netherlands B.V.
  • DEKRA SE
  • Medtronic plc
  • Siemens Healthineers AG
  • Philips N.V.
Product Code: CMI10296

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Generative AI Medical Device Validation Market, By Device Type
    • Global Generative AI Medical Device Validation Market, By Validation Type
    • Global Generative AI Medical Device Validation Market, By Deployment Mode
    • Global Generative AI Medical Device Validation Market, By Application
    • Global Generative AI Medical Device Validation Market, By End User
    • Global Generative AI Medical Device Validation Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Component Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Industry Trends

4. Global Generative AI Medical Device Validation Market, By Device Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Generative AI-Enabled Software as a Medical Device (SaMD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • AI-Enabled Medical Devices with Embedded Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Generative AI-Enabled Clinical Decision Support Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Generative AI-Enabled Diagnostic Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Generative AI Medical Device Validation Market, By Validation Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Model Performance Validation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Clinical Validation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Safety and Risk Validation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Usability and Human Factors Validation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Post-Market Performance Validation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Generative AI Medical Device Validation Market, By Deployment Mode, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Cloud-Based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • On-Premises
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Hybrid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Generative AI Medical Device Validation Market, By Application, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Medical Imaging and Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Clinical Decision Support
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Patient Monitoring and Predictive Analytics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Clinical Documentation and Reporting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Treatment Planning and Personalized Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Generative AI Medical Device Validation Market, By End User, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Medical Device Manufacturers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Hospitals and Healthcare Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Academic and Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Regulatory Testing and Validation Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Generative AI Medical Device Validation Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Validation Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Validation Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Validation Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Validation Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Validation Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Validation Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Deployment Mode, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • SE UL Solutions Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SGS SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Intertek Group plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • TUV SUD AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • TUV Rheinland AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BSI Group The Netherlands B.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DEKRA SE
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Philips N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!